• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

    5/11/26 5:00:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials
    Get the next $BIOX alert in real time by email

    Total revenues in 3Q26 were $39.4 million

    3Q26 net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million

    Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

    Presentation of Results

    In January 2026, the Company's Pro Farm Group (PFG) business was subject to a foreclosure auction and has been classified as discontinued operations. Accordingly, unless otherwise indicated, the financial results discussed below reflect the Company's continuing operations for all periods presented, and prior-year amounts have been recast to exclude the PFG business.

    Financial & Business Highlights

    • Total revenues were $39.4 million in 3Q26, a 23% year-over-year decline, reflecting softer demand and competitive pressures in Crop Protection, together with the ongoing transition in Seeds. Crop Nutrition revenues increased 15% during the quarter.
    • Gross profit was $12.7 million, with gross margin of 32%, reflecting lower revenues and product mix effects across segments. Crop Nutrition results were impacted by a non-recurring obsolescence adjustment in inoculants related to inventory normalization efforts.
    • SG&A expenses declined 16% year over year, reflecting continued execution of organizational streamlining and cost management initiatives across the continuing operations.
    • Net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million, primarily reflecting lower gross profit and the absence of prior-year non-cash income associated with the reorganization in Seeds.
    • Following the Pro Farm foreclosure auction earlier this year, and the related noteholder dispute, the Company continued advancing liability management initiatives across its operating subsidiaries, including debt reprofiling efforts and a voluntary bond maturity extension process in Argentina.

    Management Review

    Mr. Federico Trucco, Bioceres' Chief Executive Officer, commented: "This quarter reflects a period of transition and operational refocusing for the Company. While market conditions in several areas of our business remain challenging, and the effects of the transition in Seeds continue to weigh on reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution across the platform.

    "During the quarter, we continued advancing initiatives aimed at simplifying the organization, improving operational efficiency, strengthening working capital management and improving cash generation and liability management across key operating subsidiaries. In parallel, we are reinforcing governance and internal processes and conducting a strategic review of our continuing operations — including initiatives focused on organizational streamlining and capital allocation optimization — to ensure that capital, management attention, and resources remain aligned with the areas where we believe we can create the greatest long-term value.

    "We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. While we continue to pursue the appropriate legal course and evaluate constructive alternatives where possible, our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the Company for a more resilient and sustainable future."

     

    Key Financial Metrics

    Table 1:
    3Q26 Key Financial Metrics 

     

    (In millions of U.S. dollars)

    3Q25

    3Q26

    %CHANGE

    Revenue by Segment

     

     

     

    Crop Protection

    30.1

    24.6

    -18%

    Seed and Integrated Products

    10.9

    3.2

    -71%

    Crop Nutrition

    10.1

    11.6

    15%

    Total Revenue

    51.1

    39.4

    -23%

    Gross Profit

    18.1

    12.7

    -30%

    Gross Margin

    35%

    32%

    -310 bpts

     

    3Q25

    3Q26

    %CHANGE

    GAAP Net income or loss

    2.3

    (10.0)

    -528%

    Adjusted EBITDA1

    9.1

    (0.6)

    -107%

     

    3Q26 Summary: Revenue performance in the third quarter reflects mixed demand dynamics across segments, particularly in Crop Protection, together with the ongoing transition in Seeds toward a more asset-light model. While these factors weighed on reported revenues, Crop Nutrition continued to grow, driven by microbeaded fertilizers.

    Gross profit and margins declined year over year, reflecting lower revenues, product mix effects, and the impact of a non-recurring obsolescence adjustment in inoculants, associated with inventory normalization efforts during the period.

    At the same time, the Company continued to execute on cost management and working capital initiatives, resulting in meaningful reductions in operating expenses and improvements in cash conversion dynamics during the quarter.

    Profitability metrics were additionally impacted by the absence of prior year non-cash income associated with changes in contractual obligations and intellectual property arrangements as part of the reorganization in Seeds, which affected year-over-year comparability.

    For a full version of Bioceres' third quarter 2026 earnings release, click here

    Fiscal Third Quarter 2026 Earnings Conference Call

    Management will host a conference call and question-and-answer session, which will be accompanied by a presentation available during the webcast or accessed via the investor relations section of the company's website.

    To access the call, please use the following information:

     

    Date: Wednesday, May 12, 2026

     

     

     

    Time: 8:30 a.m. EST, 5:30 a.m. PST

     

    Please dial in 5-10 minutes prior to the start time to register and join. The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website here.

     

    US Toll Free dial-in number: 1-833-461-5787

     

     

    International dial-in numbers: Click here

     

     

     

    Conference ID: 717574163

     

     

     

    Webcast: Click here

     

     

     

    About Bioceres Crop Solutions Corp.

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation Crop Nutrition and Protection solutions. For more information, visit here.

    Forward-Looking Statements

    This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial data, and any such forward-looking statements involve risks, assumptions and uncertainties. These forward-looking statements include, but are not limited to, whether (i) the health and safety measures implemented to safeguard employees and assure business continuity will be successful and (ii) we will be able to coordinate efforts to ramp up inventories. Such forward-looking statements are based on management's reasonable current assumptions, expectations, plans and forecasts regarding the company's current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management's expectations or could affect the company's ability to achieve its strategic goals, including the uncertainties relating to the other factors that are described in the sections entitled "Risk Factors" in the company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.

     
     

    Unaudited Consolidated Statement of Comprehensive Income

    (Figures in million of U.S. dollars) 

     

    Continuing operations

    Three-month period ended

    03/31/2026

    Three-month period ended

    03/31/2025

    Revenues from contracts with customers

    38.2

    50.1

    Initial recognition and changes in the fair value of biological assets at the point of harvest

    1.2

    1.0

    Cost of sales

    (26.7)

    (33.0)

    Gross profit

    12.7

    18.1

    % Gross profit

    32%

    35%

    Operating expenses

    (18.0)

    (21.3)

    Share of profit of JV

    0.5

    (0.9)

    Change in net realizable value of agricultural products

    (0.2)

    (0.2)

    Other income or expenses, net

    0.7

    8.8

    Operating profit

    (4.3)

    4.3

    Financial result

    (9.7)

    (5.6)

    Profit/(loss) before income tax

    (14.1)

    (1.2)

    Income tax

    4.0

    3.6

    Profit/(loss) for the period from continuing operations

    (10.0)

    2.3

     

     

     

    Discontinued operations

     

     

    Loss for the period from discontinued operations

    -

    (3.9)

    Loss for the period from discontinued operations

    -

    (3.9)

     

     

     

    Other comprehensive profit/loss

    0.3

    (0.8)

    Total comprehensive profit/(loss)

    (9.7)

    (2.4)

     

     

     

    Profit/(loss) for the period of continuing operations attributable to

     

     

    Equity holders of the parent

    (9.0)

    2.6

    Non-controlling interests

    (1.1)

    (0.3)

     

    (10.0)

    2.3

     

     

    Weighted average number of shares

     

     

    Basic

    63.6

    62.8

    Diluted

    63.6

    62.8

     
     
     
     

    Unaudited Consolidated Statement of Financial Position

    (Figures in million of U.S. dollars) 

     

     

     

    ASSETS

    31/03/2026

     

    30/06/2025

    CURRENT ASSETS

     

     

     

    Cash and cash equivalents

    14.4

     

    32.7

    Other financial assets

    0.5

     

    2.0

    Trade receivables

    136.3

     

    165.9

    Other receivables

    13.0

     

    15.9

    Recoverable income tax

    1.4

     

    1.9

    Inventories

    48.4

     

    87.6

    Biological assets

    4.4

     

    2.4

    Assets subject to foreclosure

    42.4

     

    -

    Total current assets

    260.7

     

    308.3

    NON-CURRENT ASSETS

     

     

     

    Other financial assets

    0.0

     

    0.0

    Trade receivables

    4.8

     

    2.5

    Other receivables

    25.7

     

    23.7

    Recoverable income tax

    0.0

     

    0.0

    Deferred tax assets

    6.5

     

    4.9

    Investments in joint ventures and associates

    40.6

     

    39.4

    Investment properties

    -

     

    0.6

    Property, plant and equipment

    60.0

     

    74.6

    Intangible assets

    83.9

     

    181.2

    Goodwill

    36.1

     

    112.2

    Right of use asset

    11.4

     

    16.4

    Total non-current assets

    268.9

     

    455.3

    Total assets

    529.6

     

    763.6

     

    LIABILITIES

    31/03/2026

     

    30/06/2025

    CURRENT LIABILITIES

     

     

     

    Trade and other payables

    79.6

     

    96.4

    Borrowings

    66.4

     

    119.7

    Employee benefits and social security

    3.6

     

    6.2

    Deferred revenue and advances from customers

    2.8

     

    4.3

    Income tax payable

    4.8

     

    0.5

    Consideration for acquisition

    2.1

     

    1.8

    Secured notes

    108.3

     

    102.3

    Lease liabilities

    2.6

     

    6.9

    Liabilities subject to foreclosure

    27.4

     

    -

    Total current liabilities

    297.5

     

    338.0

    NON-CURRENT LIABILITIES

     

     

     

    Trade and other payables

    46.2

     

    48.5

    Borrowings

    54.1

     

    38.2

    Deferred revenue and advances from customers

    1.4

     

    1.4

    Joint ventures and associates

    0.7

     

    1.0

    Deferred tax liabilities

    24.3

     

    30.1

    Provisions

    1.0

     

    1.3

    Consideration for acquisition

    0.0

     

    0.4

    Secured notes

    -

     

    -

    Lease liabilities

    8.6

     

    9.5

    Total non-current liabilities

    136.4

     

    130.4

    Total liabilities

    433.9

     

    468.4

    EQUITY

     

     

     

    Equity attributable to owners of the parent

    67.7

     

    265.4

    Non-controlling interest

    27.9

     

    29.8

    Total equity

    95.7

     

    295.2

    Total equity and liabilities

    529.6

     

    763.6

     
     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260511356435/en/

    Bioceres Crop Solutions

    Paula Savanti

    Head of Investor Relations

    investorrelations@biocerescrops.com

    Get the next $BIOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOX

    DatePrice TargetRatingAnalyst
    10/22/2025Outperform → Perform
    Oppenheimer
    9/10/2025$2.50Buy → Hold
    Canaccord Genuity
    7/19/2024$17.00Buy
    Canaccord Genuity
    7/2/2024$15.00Buy
    ROTH MKM
    4/6/2023$15.00Outperform
    Oppenheimer
    9/30/2022$22.50Buy
    Canaccord Genuity
    10/8/2021$21.00Buy
    ROTH Capital
    More analyst ratings

    $BIOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Duraiswami Narain

    3 - Bioceres Crop Solutions Corp. (0001769484) (Issuer)

    5/12/26 5:20:03 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form 3 filed by new insider Simmermacher Ezequiel

    3/A - Bioceres Crop Solutions Corp. (0001769484) (Issuer)

    5/11/26 5:31:18 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    New insider Mago Yogesh claimed ownership of 55,399 units of Ordinary Shares (SEC Form 3)

    3 - Bioceres Crop Solutions Corp. (0001769484) (Issuer)

    5/11/26 5:25:52 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

    Total revenues in 3Q26 were $39.4 million 3Q26 net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Presentation of Results In January 2026, the Comp

    5/11/26 5:00:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

    The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, M

    5/4/26 4:05:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2026. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Ezequiel Simmermacher, and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer s

    5/4/26 4:05:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bioceres downgraded by Oppenheimer

    Oppenheimer downgraded Bioceres from Outperform to Perform

    10/22/25 10:10:01 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Bioceres from Buy to Hold and set a new price target of $2.50

    9/10/25 7:58:04 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Bioceres with a new price target

    Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00

    7/19/24 8:32:10 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    SEC Filings

    View All

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    6/1/26 10:16:16 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    5/12/26 4:01:44 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    3/17/26 9:16:47 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Financials

    Live finance-specific insights

    View All

    Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

    Total revenues in 3Q26 were $39.4 million 3Q26 net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Presentation of Results In January 2026, the Comp

    5/11/26 5:00:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

    The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, M

    5/4/26 4:05:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2026. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Ezequiel Simmermacher, and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer s

    5/4/26 4:05:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bioceres Crop Solutions Corp.

    SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    10/23/24 2:32:38 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp.

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    9/20/24 9:09:41 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp. (Amendment)

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    3/25/24 8:58:35 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials